ArticleBlood2025

DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera.

Ghaith Abu-Zeinah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.